Both exogenous exposure to carcinogens and endogenous biological processes are known to cause mutations in DNA. Chemical carcinogens induce mutations by forming covalent adducts with the nucleotides in DNA, increasing the probability of enzymatic errors during DNA replication (1) . Studies have shown that some carcinogenic agents produce a specific mutational pattern, a "DNA fingerprint" (2), because specific types and locations of DNA adducts are linked to a specific mutational spectrum in a DNA sequence (3) . The mutational spectra of cancer-related genes differ depending on cancer type, but provide a molecular link between cancer and etiological agent, and give clues to the nature of carcinogens responsible for genetic alterations (4) .
Specifically, the study of mutational spectra of p53 and other important cancer-related genes can give us clues about carcinogen-DNA interactions, functions of gene products and mechanisms of carcinogenesis in specific tissues (3 Another association between p53 mutational spectra and carcinogen exposure was found in skin carcinoma caused by UV irradiation -p53 mutations are located at dipyrimidine sites, generating CC → TT double-base transitions (14) . Furthermore, the p53 mutational pattern in radon-associated lung cancer from uranium miners differs from the one in lung cancer caused by smoking alone (15) . Moreover, liver angiosarcomas of vinyl chloride-exposed factory workers have higher frequency of p53 A:T → T:A transversions comparing to sporadic angiosarcoma (16) .
In summary, these differences in mutational frequency and spectra among human cancer types may be traced to exogenous and endogenous factors to human carcinogenesis (17) . About one hundred AAN cases have been identified so far in Belgium among women undergoing a slimming treatment involving ingestion of A. fangchi that was inadvertently put into the slimming pills for several months (29, 32, 33 (38) . Bilateral nephrectomy was performed several years before bladder cancers were diagnosed, preventing the possibility that upper urothelial cancers could have been detected (38) .
AA as a mutagen
AA forms covalent DNA adducts in rodents (40, 41, 42) as well as in AAN patients (36, 43, 44, 45) . Covalently bound AA-DNA adducts, present for the life time in rodents and for many years in humans, now are considered to be a reliable biomarker of exposure to this environmental carcinogen (25, 27, 44, 45, 46) . The relationship between AA-induced DNA adducts and mutations in rat liver and kidney (the tissues that activate AA) was recently reported by Mei et al. (28) . Strong linear dose-responses for AA-induced DNA adducts were found in treated rats..
Kidneys had at least two-fold higher levels of DNA adducts and mutation frequencies than livers, with no significant difference between the mutation spectra in AA-treated livers and kidneys (mostly A:T → T:A transversions). However, there was a significant difference between the mutation spectra in both kidney and liver of AAtreated and control rats (mostly G:C → A:T transitions). These results link AA exposure that eventually results in kidney tumors in rats, to a significant increase in AA-induced DNA adduct formation with a characteristic mutation in kidney tissue.
Although the same treatment does not produce tumors in rat liver, it does induce DNA adducts and mutations in this tissue, albeit at lower levels than in the kidney (28) .
Moreover, the mutation frequency in kidneys of AA-treated rats was shown to correlate with tumor incidence in the kidney (53).
Aristolochic acid nephropathy and endemic (Balkan) nephropathy
Endemic nephropathy (EN) is characterized by chronic tubulointerstitial nephritis with slow progression to terminal renal failure. EN is present in several rural areas in the valleys of big Danube tributaries in Bosnia and Herzegovina, Bulgaria, Croatia, Romania and Serbia affecting approximately 2-7% of exposed rural farming population (54, 55) . EN has several epidemiological characteristics: (i) it is present only in certain villages with completely unaffected villages located in close proximity; (ii) household (not inherited) pattern of disease was observed; (iii) it affects only adult population; (iv) there is strong association (~30-50%) with upper urothelial cancers (UUC). The specific mortality associated with UUC in this region is 50 times higher than elsewhere in Europe (56) . Epidemiologic findings and striking geographical correlation of two very rare diseases pointed from the beginning to a common environmental etiological agent. EN was first described more than 50 years ago and many toxic agents have been investigated (57) . In the last two decades ochratoxin A (OTA) was a major focus of interest. This hypothesis was supported by the detection of so-called "OTA-associated" DNA adducts (deoxyguanosin adducts) in urothelial tumors of Bulgarian patients (58) . However, presence of OTA in these adducts could not be confirmed (59, 60) . Although there are reports on higher concentrations of OTA in food, blood and urine of inhabitants in EN regions compared to other regions, there is no evidence that OTA is a risk factor for EN (61, 62 Safety Authority also concluded that epidemiological data are incomplete and do not justify the classification of OTA as a human renal carcinogen (64) . OTA induces renal adenomas in rodents and no urothelial cancers. This is one of the strongest arguments against OTA as a major risk factor for EN-associated urothelial malignancy.
Pathological findings in EN differ also in some very important elements from findings in animal models of OTA nephrotoxicity but are almost identical with findings in aristolochic acid nephropathy (30) .
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